In 1985 was created Meusinvest, which is appeared as VC. The company was established in Europe in Belgium. The main department of described VC is located in the Liu00e8ge.
Among the most popular portfolio startups of the fund, we may highlight Miracor Medical, YouScribe, Osivax. The fund has specific favorite in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Belgium. We can highlight the next thriving fund investment areas, such as Music, Software. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Meusinvest, startups are often financed by Peppermint Venture Partners, Spreds, SHS Gesellschaft fur Beteiligungsmanagement. The meaningful sponsors for the fund in investment in the same round are LeanSquare, Spreds, Inventures SA. In the next rounds fund is usually obtained by Inventures SA, Spreds, Spinventure.
The common things for fund are deals in the range of 5 - 10 millions dollars. The high activity for fund was in 2018. Speaking about the real fund results, this VC is 6 percentage points less often commits exit comparing to other organizations. When the investment is from Meusinvest the average startup value is 1-5 millions dollars. The fund is constantly included in less than 2 deals per year.
The overall number of key employees were 1.
|Banco Sabadell Mexico||Distrito Federal, Mexico, Mexico City|
|Charles River Laboratories International||Massachusetts, United States, Wilmington|
|First West Capital||-|
|HSBC Private Equity (Asia)||China, Hong Kong, Hong Kong Island|
|Microequities||Australia, New South Wales, Sydney|
|Moving Capital||California, Santa Monica, United States|
|Pulse Venture Capital||-|
|RMC Dr. Reineck Management & Consulting||Baden-Württemberg, Baden-Wurttemberg, Germany|
|The Whittemore Collection||New York, Port Chester, United States|
|TRUIM Partners||Japan, Tokyo|
|$47M||16 Feb 2022||Belgium, Walloon Brabant, Belgium|
|$1M||27 Jan 2022||La Hulpe, Brabant Wallon, Belgium|
|$4M||20 Jan 2022||Franche-Comte, Bourgogne-Franche-Comté, France|
|$53M||24 Dec 2021||Liege, Liège, Belgium|
|$13M||06 Dec 2021||France, Auvergne-Rhône-Alpes, France|
|$10M||03 Jun 2021||Liege, Liège, Belgium|
|$3M||07 Apr 2021||Mont-saint-guibert, Brabant Wallon, Belgium|
|$25M||17 Feb 2021||Liège, Liège, Belgium|
GeneQuine Biotherapeutics GmbH
|$6M||15 Feb 2021||Germany, Baden-Württemberg, Germany|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.